83 related articles for article (PubMed ID: 18024617)
1. Novel thrombopoietic agents.
Andemariam B; Psaila B; Bussel JB
Hematology Am Soc Hematol Educ Program; 2007; ():106-13. PubMed ID: 18024617
[TBL] [Abstract][Full Text] [Related]
2. The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia.
Levy B; Arnason JE; Bussel JB
Curr Opin Oncol; 2008 Nov; 20(6):690-6. PubMed ID: 18841052
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura.
Wang T; Wang Z; Yang R
Crit Rev Oncol Hematol; 2011 Mar; 77(3):172-83. PubMed ID: 20378370
[TBL] [Abstract][Full Text] [Related]
5. Biologic aspects of thrombopoietins and the development of therapeutic agents.
Solberg LA
Curr Hematol Rep; 2005 Nov; 4(6):423-8. PubMed ID: 16232377
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C.
Dusheiko G
Clin Liver Dis; 2009 Aug; 13(3):487-501. PubMed ID: 19628164
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin factors.
Wei P
Cancer Treat Res; 2011; 157():75-93. PubMed ID: 21052951
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietic agents in immune thrombocytopenia.
Ghanima W; Bussel JB
Semin Hematol; 2010 Jul; 47(3):258-65. PubMed ID: 20620437
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietic agents: there is still much to learn.
Bussel JB; Lakkaraja M
Presse Med; 2014 Apr; 43(4 Pt 2):e69-78. PubMed ID: 24680422
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia.
Huang CE; Chen YY; Chang JJ; Kuan FC; Lee KD; Lu CH; Lung J; Shen CH; Chen CC
Hematology; 2017 Jan; 22(1):54-60. PubMed ID: 27396368
[TBL] [Abstract][Full Text] [Related]
12. Clinical findings with the first generation of thrombopoietic agents.
Vadhan-Raj S
Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions.
Haznedaroglu IC; Goker H; Turgut M; Buyukasik Y; Benekli M
Clin Appl Thromb Hemost; 2002 Jul; 8(3):193-212. PubMed ID: 12361196
[TBL] [Abstract][Full Text] [Related]
14. Toxicities of the thrombopoietic growth factors.
Cuker A
Semin Hematol; 2010 Jul; 47(3):289-98. PubMed ID: 20620441
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietic growth factors and cytokines.
Vadhan-Raj S; Cohen V; Bueso-Ramos C
Curr Hematol Rep; 2005 Mar; 4(2):137-44. PubMed ID: 15720963
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoiesis-stimulating agents and myelodysplastic syndromes.
Brierley CK; Steensma DP
Br J Haematol; 2015 May; 169(3):309-23. PubMed ID: 25659186
[TBL] [Abstract][Full Text] [Related]
17. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
Journeycake JM
Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617
[TBL] [Abstract][Full Text] [Related]
18. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection.
Afdhal NH; McHutchison JG
Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():29-39. PubMed ID: 17958517
[TBL] [Abstract][Full Text] [Related]
19. Infectious causes of chronic immune thrombocytopenia.
Stasi R; Willis F; Shannon MS; Gordon-Smith EC
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1275-97. PubMed ID: 19932434
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
Wang L; Li Y; Hou M
Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
